SUTRO BIOPHARMA INC COM SHS

SUTRO BIOPHARMA INC COM SHS is a security (CUSIP 869367201) tracked across SEC portfolio filings. 74 institutional managers reported $329.6M on Form 13F as of 2026-06-30; 3 registered fund positions totaling $805K via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 74 managers by value.

ManagerLocationValueShares
BVF INC/ILSan Francisco, CA$31.2M1,251,788
Affinity Asset Advisors, LLCNew York, NY$26.6M1,069,519
Samsara BioCapital, LLCPalo Alto, CA$26.5M1,062,872
Kynam Capital Management, LPPRINCETON, NJ$21.7M872,558
ORBIMED ADVISORS LLCNew York, NY$20.0M801,144
PERCEPTIVE ADVISORS LLCNEW YORK, NY$17.8M715,307
EVENTIDE ASSET MANAGEMENT, LLCBoston, MA$17.8M715,307
RA CAPITAL MANAGEMENT, L.P.Boston, MA$17.8M715,307
Point72 Asset Management, L.P.Stamford, CT$17.2M692,111
ADAR1 Capital Management, LLCAUSTIN, TX$13.1M524,441
Velan Capital Investment Management LPAlpharetta, GA$12.8M512,160
Balyasny Asset Management L.P.Chicago, IL$11.6M465,792
Woodline Partners LPSan Francisco, CA$11.4M457,441
UBS Group AGZurich, V8$9.8M392,871
ACUTA CAPITAL PARTNERS, LLCRedwood City, CA$6.7M269,425

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Fidelity Series Total Market Index FundFidelity Concord Street Trust$672K0.06%
TIFF MULTI-ASSET FUNDTIFF Investment Program$113K0.82%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$19K0.05%

More